Yes, the charts tell a dismal story and the 2 updates re Phosphate and Peru, followed by the quarterly have not supported the sp.
What is lacking is specific news - ie assays. The quarterly detailed assays expected early in 1st quarter 2023 - hello - we are past early. Maybe this was repeating a comment from last year - if so all it does is highlight it did not happen. [the rock breaker approach strikes again]
Further into the quarterly, assays expected in coming weeks - it would be great if released by mid Feb. Meanwhile buyers are positioning themselves @ 2c to take advantage of any delay re the assays.
Hopefully it does not go sub 2c - there is still just over 1m shares wanted at 2.1 2.2
ICG Price at posting:
2.2¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)